These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5309002)

  • 21. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fungal strains and the development of tolerance against natamycin.
    Streekstra H; Verkennis AE; Jacobs R; Dekker A; Stark J; Dijksterhuis J
    Int J Food Microbiol; 2016 Dec; 238():15-22. PubMed ID: 27589020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
    Moosa MY; Alangaden GJ; Manavathu E; Chandrasekar PH
    J Antimicrob Chemother; 2002 Jan; 49(1):209-13. PubMed ID: 11751792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fungostatic activity in vitro of the new antibiotic--pimaricin (natamycin)].
    Porebska A; Laskownicka Z; Zemburowa K
    Med Dosw Mikrobiol; 1971; 23(1):71-6. PubMed ID: 5314225
    [No Abstract]   [Full Text] [Related]  

  • 28. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
    Araujo R; Pina-Vaz C; Rodrigues AG
    Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex.
    Vaezi A; Fakhim H; Arastehfar A; Shokohi T; Hedayati MT; Khodavaisy S; Rezaei-Matehkolaei A; Badiee P; Hagen F; Lass-Flörl C; Dannaoui E; Meis JF; Badali H
    Mycoses; 2018 Feb; 61(2):134-142. PubMed ID: 29064123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
    Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [On the action of antimycotics on the growth of aerial mycelia in certain fungi].
    Wolters B
    Arch Mikrobiol; 1966 May; 53(4):389-95. PubMed ID: 6011280
    [No Abstract]   [Full Text] [Related]  

  • 33. Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.
    Balajee SA; Lindsley MD; Iqbal N; Ito J; Pappas PG; Brandt ME
    J Clin Microbiol; 2007 Aug; 45(8):2701-3. PubMed ID: 17537938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
    Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antifungal activity of natamycin toward molds isolated from commercially manufactured poultry feed.
    Brothers AM; Wyatt RD
    Avian Dis; 2000; 44(3):490-7. PubMed ID: 11006995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspergillus nidulans is frequently resistant to amphotericin B.
    Kontoyiannis DP; Lewis RE; May GS; Osherov N; Rinaldi MG
    Mycoses; 2002 Nov; 45(9-10):406-7. PubMed ID: 12421291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.
    Martinez J; Torres JM; Arteaga F; Foz-Tena A
    Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
    Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
    Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J; Rimek D; Kappe R
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.